HVC KYOTO, an innovation platform supported by JETRO, the Kyoto Prefectural Government, Kyoto City, and Kyoto Research Park (KRP) to assist cross-border healthcare business development, has selected 12 finalists for the HVC Demo Day to be held over July 13–14, 2026. The finalist pitch on the second day will be open to the general public via advance registration.

Event Overview: - Name: HVC KYOTO (Healthcare Venture Conference Kyoto) 2026 Demo Day - Dates: July 13 (Mon) Day 1 (Business meetings, Reception), July 14 (Tue) Day 2 (Finalist pitches, Keynote) - Venue: Buzz Hall, B1F, KRP Building 4 - Activities: Pitches, Keynotes by domestic and international experts, Networking

In addition to the 12 finalists, three startups from the UK are scheduled to present: Argonaute RNA Ltd. (Biotech), Impli Health (MedTech), and Neubond Ltd. (MedTech).

HVC provides growth opportunities for seed to early-stage startups, having selected 194 startups over the past 10 years and facilitating over 83 billion JPY in cumulative funding. In February 2025, it received the 'Minister of Economy, Trade and Industry Award' at the 7th Japan Open Innovation Prize.

FACT BOX

  • Source: PR TIMES
  • Category: Event